Lectures and conversations

Welcome to the 20th Annual Research Presentations


Join us as young researchers showcase groundbreaking findings across clinical medicine. Hosted at Haukeland University Hospital, this three-day event features both poster and oral presentations, offering a unique opportunity for academic inspiration, networking, and insight into the future of medical research.

Download Programme  (external link)

The following times are approximate. If presenters finish early, we may run slightly ahead of schedule. All presentaions will be held in English.

Wednesday, 28.01.2026 – Posters

Location: Main foyer, Sentralblokka, Haukeland University Hospital

Session 1: Cardiology and Endocrinology

09:30 – Most Champa Begum – Proteomic signatures link clinical parameters to the risk of microvascular complications in type 2 diabetes

09:35 – Miguel Angel Juarez Garzon – Phenotypic Clustering of Pediatric Diabetes Reveals Clinical, Genetic and Metabolic Differences Independent of Autoantibody Status

09:40 – Sebastian Solhiem – Trends and Outcomes in Diabetic Ketoacidosis: A 10-Year Retrospective Study at a Norwegian University Hospital

09:45 – Hilde Halland – Progressive inflammation in proteomic profile underlies increased blood pressure in obese individuals

09:50 – Elise Botnevik Almeland – The impact of statin use on calcified plaque burden in patients with nonobstructive coronary artery disease

09:55 – Silja Hanseth – Coronary calcium score and CT angiography in myocardial infarction with nonobstructive coronary arteries

10:00 – Aisteja Selmyte-Besuspare – Sex hormones as markers of cardiovascular organ damage in women with overweight and obesity

Session 2: Neurology and Psychiatry

10:15 – Max Korbmacher – Normative Modelling of Brain Volume Enables Diagnostic and Prognostic Stratification in Multiple Sclerosis

10:20 – Max Korbmacher – Robust Predictors of Disability Progression & Processing Speed Decline
10:25 – Anna Rubiolo – Complex I deficiency in POLG and Parkinson’s disease: differential involvement of mtDNA defects

10:30 – Kira Höffler – Epigenetic Markers of Response to Psychotherapy in Obsessive-Compulsive Disorder

10:35 – Kjersti Sellevåg – Diverging trajectories of depressive symptoms during ECT: Towards personalized treatment

Session 3: Infectious and Inflammatory Diseases

10:55 – Anne Kristine Brekka – Inspiratory laryngeal observations during non-invasive ventilation titration in individuals with COPD

11:00 – Petrine Solli – A randomized controlled trial (RCT), adding inspiratory muscle training to standard treatment for exercise-induced laryngeal obstruction (EILO)

11:05 – Amalie Borlaug – Antibody landscapes following seasonal influenza vaccination in children and pregnant women in Bangladesh

11:10 – Guri Kringeland – Antibiotic use and antibiotic resistance genes in the lower airways in patients with chronic lung disease

11:15 – Jahid Tipu – Diversity of domestic and imported assemblages of Giardia in Norway and multi-locus sequence typing of domestic assemblage A isolates

11:20 – Adrianna Jebrzycka – Reduced interferon-stimulated signature in the thymus has limited impact on peripheral T cell transcriptomes in Aire-deficient mice

11:25 – Ala Bassam Qadan – Adalimumab in the management of refractory Idiopathic Retinal Vasculitis, Aneurysms, and Neuroretinitis (IRVAN) syndrome: A Case Report

Session 4: Oncology

12:30 – Karoline Fjeldstad – Multiparametric flow cytometry panel reveals fibroblast heterogeneity in head and neck cancers
12:35 – Oda Fløtre – Capturing cervical cancer diversity: patient-derived organoid models for preclinical drug testing

12:40 – May Eriksen Gjerstad – IL22R-targeting combinatorial CAR T cells for solid malignancies

12:45 – Angela Mesquita – Development of patient-derived xenograft (PDX) models of myelodysplastic syndromes

12:50 – Nicolas Fuenzalida – Myeloid-Specific Immunomodulatory Profiles Predict Relapse in Patients With Non-metastatic Proximal Colon Cancer

12:55 – Anna Gorbunova – Spatial mapping of PD1–PD-L2 interactions suggests an additional checkpoint axis in non–small cell lung cancer

13:00 – Ghazal Lessan Toussi – Combining PLA and Imaging Mass Cytometry for Immune Checkpoint Signalling

13:15 – Lucrezia Berton – Chemotherapy reshapes the evolutionary trajectories of breast cancer

13:20 – Mari Eskild Rasmussen – Impact of TP53 and HRD status on 5-year survival in TNBC treated with sequential neoadjuvant olaparib and high-dose cyclophosphamide/carboplatin (the PETREMAC trial)

13:25 – Sunniva Brownrigg – An ER-stress inducing mutation of the carboxyl ester lipase gene (CEL) stimulates KRAS-driven early pancreatic carcinogenesis

13:30 – Lorena Larios – Modulation of Drug Sensitivity Testing by Head and Neck Cancer Cell Model Systems

13:35 – Alexander Marks – Stromal Alpha-Smooth Muscle Actin Predicts Aggressive Disease in HPV-Positive Penile Squamous Cell Carcinoma Patients

13:40 – Daniel Rodrigo Villarroel Fernandez – Experimental Induction of Cancer-Associated Fibroblasts (CAF) Phenotypes for Functional Studies of the Tumor Microenvironment

Session 5: Genetics and Pathology

13:55 – Nicolas Fragoso Bargas – GWAS of infant and early childhood height identifies 179 loci and reveals three clusters with different biology

14:00 – Adina Lupu – Sex-specific effects on the genetic architecture of childhood height

14:05 – Jennifer Janani Antonychasan – Organizational Readiness for AI in Pathology: A Regional Pre-Implementation Survey Study

Thursday, 29.01.2026 – Oral Presentations

Location: Room B301, 3rd floor, Sentralblokka, Haukeland University Hospital

Session 1: Neurological Diseases

10:15 – Jenny Linnea Victoria Lindros – Medication Use Trajectories in Myasthenia Gravis Pregnancies: A Drug Utilization Study

10:30 – Daniela Contreras – CGRP monoclonal antibodies for migraine and the risk of adverse pregnancy outcomes: Norway’s Headache Health – a nationwide registry-based cohort study from 2018 to 2022

10:45 – Shamundeeswari Anandan – Brain-derived blood extracellular vesicles as potential treatment response biomarkers in multiple sclerosis patients receiving anti-CD20 therapy

11:00 – Dewaki Chhetri – Rethinking Limbal Stem Cell Deficiency: Comparative Analysis of Experimental Models and Epithelial Marker Expression

Session 2: Endocrinology & Cardiology

11:30 – Isil Kucuka – Primary Adrenal Insufficiency in the Young, Consider APS-1

11:45 – Aishwarya Pavithram – Functional analyses improve HNF1B diagnostics and prevalence in Norwegian MODY Diabetes Registry and Norwegian Childhood Diabetes Registry

12:00 – Viola I.L Thulin – Point-of-Care High-sensitivity cardiac troponin testing in the Emergency department – Insights from the WESTCOR-POC Randomized Trial

12:15 – Silja Hanseth – Relationship between coronary artery calcium score and plaque vulnerability by coronary CT angiography in non-obstructive coronary artery disease

Session 3: Genetics and Oncology

13:15 – Michelle B Verstraaten – Fine-scale population structure in the Norwegian Mother, Father, and Child Cohort Study (MoBa): quality control of new genotype set

13:30 – Palesa Chabunya – Perceptions and experiences of breast cancer patients in southern Malawi

13:45 – Tessa Lohr – Dual interactions between breast cancer and peripheral neurons: Investigating the role of axon guidance factors

14:15 – Lorena Larios – Novel double functionalized nanodiamonds for targeted treatment to prevent oral cancer recurrence

14:30 – Jostein Sæterstøl – Is Visceral Adipose Tissue Metabolism Linked to Aggressiveness in Endometrial Cancer?

14:45 – Luka Tandaric – Rethinking High-Grade Serous Ovarian Carcinoma: Towards Personalized Immunotherapy through Preclinical, Translational and Clinical Evaluation of Combined CD73 and PD-L1 Blockade

Friday, 30.01.2026

Location: Main foyer, Sentralblokka, Haukeland University Hospital
12:00 – Award Ceremony